BILLIE NELSON: Open Payments
NPI 1578165858 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$207 in 9 payments from 7 companies in 2025. Trend: 2023 $55 · 2024 $0 · 2025 $207
Food & beverage: $207
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $45 |
| UCB, Inc. | 2 | $41 |
| ABBVIE INC. | 1 | $30 |
| Merz Pharmaceuticals, LLC | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Grifols USA, LLC | 1 | $22 |
| DePuy Synthes Sales Inc. | 1 | $16 |
Products named: UPLIZNA, BOTOX, Xeomin, REXULTI, Gamunex-C, Rystiggo, Nayzilam, VIVIGEN MIS DELIVERY SYSTEM.
Industry payments across AR — which companies pay providers there.
